PetCareClub offers a range of pet supplies including treatments for dogs, cats, and horses, as well as homeopathic products and supplements. The company's offerings include flea and tick treatments, wormers, skincare, joint care, and hygiene products.

PetCareClub

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Metric
Company Name	PetCareClub	ZOETIS INC.
Symbol		ZTS
MSH ID	COM:PETCARECLUB	COM:ZOETIS
Market	PRIVATE	STOCKS
Sector	Consumer Goods	Healthcare
Industry	Pet Care	Drug Manufacturers - Specialty & Generic
Country	US	US
Stage
Employee Count		14.10K
Website	petcareclub.com	zoetis.com
LinkedIn
Founders

Metric
Market Cap		79.74B
Enterprise Value
Monthly Web Traffic		457
Web Traffic Growth		-0.79
Valuation
Raised Capital

Metric
Revenue		8.54B
Revenue (LTM)
Revenue (NTM)
Gross Profit		5.83B
EBITDA		3.56B
Operating Income		3.07B
Net Income		2.34B
EPS		5.08
Diluted EPS		5.07
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.70
Operating Profit Margin		0.37
EBITDA Margin		0.42
Net Profit Margin		0.27
Return on Equity		0.49
Return on Assets		0.17
Return on Capital Employed		0.27

COM:PETCARECLUB

PetCareClub

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		38.27
P/B Ratio		17.18
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		9.98
EV Multiple		23.13

Metric
Days Sales Outstanding		54.81
Days Payables Outstanding		56.97
Days Inventory Outstanding		364.72
Operating Cycle		418.76
Cash Conversion Cycle		363.04
Asset Turnover		0.63

Metric
Operating Cash Flow		2.35B
Free Cash Flow		1.62B
Cash Flow to Debt		0.40
Operating Cash Flow/Sales		0.30
Free Cash Flow Yield		0.02

Metric
Cash & Equivalents		2.04B
Accounts Receivable		-102M
Inventory		2.56B
Goodwill		2.76B
Debt to Capitalization		0.58
Debt to Assets		0.48
Current Ratio		3.87
Quick Ratio		2.09

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.01
R&D to Revenue		0.07
SG&A to Revenue